Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease

BACKGROUND: Low molecular weight heparins hold several advantages over unfractionated heparin including convenience of administration. Enoxaparin is one such heparin licensed in the UK for use in unstable coronary artery disease (unstable stable angina and non-Q wave myocardial infarction). In these...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholson, Tricia, McGuire, Alistair, Milne, Ruairidh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59676/
https://www.ncbi.nlm.nih.gov/pubmed/11701090
http://dx.doi.org/10.1186/1471-2261-1-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59676/
https://www.ncbi.nlm.nih.gov/pubmed/11701090
http://dx.doi.org/10.1186/1471-2261-1-2

Ejemplares similares